| Primary |
| Diabetes Mellitus |
44.5% |
| Hypertension |
26.4% |
| Type 2 Diabetes Mellitus |
4.4% |
| Cardiac Disorder |
3.8% |
| Anticoagulant Therapy |
2.7% |
| Blood Pressure |
2.2% |
| Blood Pressure Abnormal |
1.6% |
| Abdominal Discomfort |
1.1% |
| Blood Cholesterol |
1.1% |
| Blood Cholesterol Increased |
1.1% |
| Blood Glucose Abnormal |
1.1% |
| Cough |
1.1% |
| Feeling Of Relaxation |
1.1% |
| Hypothyroidism |
1.1% |
| Lung Infection |
1.1% |
| Memory Impairment |
1.1% |
| Promotion Of Peripheral Circulation |
1.1% |
| Renal Disorder |
1.1% |
| Sleep Disorder |
1.1% |
| Thyroid Disorder |
1.1% |
|
| Vomiting |
9.3% |
| Death |
7.0% |
| Pneumonia |
7.0% |
| Speech Disorder |
7.0% |
| Urinary Tract Infection |
7.0% |
| Arterial Occlusive Disease |
4.7% |
| Cardiac Disorder |
4.7% |
| Diabetes Mellitus |
4.7% |
| Glycosylated Haemoglobin Increased |
4.7% |
| Hypertension |
4.7% |
| Parkinson's Disease |
4.7% |
| Renal Disorder |
4.7% |
| Renal Failure Acute |
4.7% |
| Tongue Discolouration |
4.7% |
| Weight Decreased |
4.7% |
| Weight Increased |
4.7% |
| Wrong Technique In Drug Usage Process |
4.7% |
| Angioedema |
2.3% |
| Appetite Disorder |
2.3% |
| Blood Glucose Increased |
2.3% |
|
| Secondary |
| Diabetes Mellitus |
33.2% |
| Hypertension |
26.3% |
| Product Used For Unknown Indication |
10.6% |
| Type 2 Diabetes Mellitus |
10.3% |
| Drug Use For Unknown Indication |
2.6% |
| Cardiac Disorder |
2.1% |
| Blood Cholesterol Increased |
1.8% |
| Eye Disorder |
1.5% |
| Blood Pressure |
1.3% |
| Diabetes Prophylaxis |
1.3% |
| Hypothyroidism |
1.3% |
| Arrhythmia |
1.0% |
| Diuretic Therapy |
1.0% |
| Dyslipidaemia |
1.0% |
| Abdominal Discomfort |
0.8% |
| Anticoagulant Therapy |
0.8% |
| Blood Glucose Abnormal |
0.8% |
| Blood Pressure Abnormal |
0.8% |
| Emphysema |
0.8% |
| Epilepsy |
0.8% |
|
| Death |
22.8% |
| Latent Autoimmune Diabetes In Adults |
6.5% |
| Tachycardia |
5.4% |
| Ventricular Fibrillation |
5.4% |
| Weight Increased |
5.4% |
| Diabetes Mellitus |
4.3% |
| Myocardial Infarction |
4.3% |
| Nausea |
4.3% |
| Pancreatitis Acute |
4.3% |
| Pneumonia |
4.3% |
| Urticaria |
4.3% |
| Vomiting |
4.3% |
| Blood Glucose Increased |
3.3% |
| Gait Disturbance |
3.3% |
| Pyrexia |
3.3% |
| Renal Failure Acute |
3.3% |
| Throat Tightness |
3.3% |
| Weight Decreased |
3.3% |
| Abdominal Pain |
2.2% |
| Asthma |
2.2% |
|
| Concomitant |
| Diabetes Mellitus |
20.4% |
| Product Used For Unknown Indication |
18.8% |
| Hypertension |
17.2% |
| Rheumatoid Arthritis |
11.4% |
| Type 2 Diabetes Mellitus |
7.3% |
| Prophylaxis |
4.4% |
| Blood Cholesterol Increased |
3.3% |
| Cardiac Disorder |
2.0% |
| Blood Cholesterol Abnormal |
1.8% |
| Drug Use For Unknown Indication |
1.7% |
| Pain |
1.6% |
| Device Therapy |
1.5% |
| Blood Pressure |
1.4% |
| Hypercholesterolaemia |
1.3% |
| Gastric Disorder |
1.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.2% |
| Depression |
1.1% |
| Blood Cholesterol |
1.0% |
| Anticoagulant Therapy |
0.7% |
| Colorectal Cancer Metastatic |
0.7% |
|
| Vomiting |
12.6% |
| Throat Irritation |
10.5% |
| Myocardial Infarction |
6.3% |
| Oedema Peripheral |
6.3% |
| Weight Decreased |
6.3% |
| Drug Ineffective |
5.3% |
| Pain In Extremity |
5.3% |
| Venous Occlusion |
5.3% |
| Malaise |
4.2% |
| Off Label Use |
4.2% |
| Osteoarthritis |
4.2% |
| Urinary Tract Infection |
4.2% |
| Cataract |
3.2% |
| Gait Disturbance |
3.2% |
| Haemoglobin Decreased |
3.2% |
| Hypertension |
3.2% |
| Infarction |
3.2% |
| Nervousness |
3.2% |
| Parkinson's Disease |
3.2% |
| Respiratory Failure |
3.2% |
|
| Interacting |
| Diabetes Mellitus Non-insulin-dependent |
22.2% |
| Loin Pain |
22.2% |
| Cerebrovascular Accident Nos |
11.1% |
| Diabetes Mellitus |
11.1% |
| Hypertension |
11.1% |
| Hypertension Arterial |
11.1% |
| Urinary Tract Infection |
11.1% |
|
| Nausea |
50.0% |
| Renal Failure Acute |
50.0% |
|
